Glycated haemoglobin levels are related to chronic subclinical inflammation in renal transplant recipients without pre-existing or new onset diabetes

Nephrology Dialysis Transplantation

Volumn 22, Issue 7, 2007, Pages 1994-1999

  Porrini, Esteban ^a,b   Gomez, Maribel Diaz ^a   Alvarez, Alejandra ^a   Cobo, Marian ^a   Gonzalez Posada, Jose Manuel ^a   Perez, Lourdes ^a   Hortal, Luis ^c   García, José J ^d   Checa, María Dolores ^e   Morales, Adelaida ^f   Hernández, Domingo ^a   Torres, Armando ^a,b  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b Inst Reina Sofia Invest N   (Spain)

^c HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^d HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^e HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^f HOSPITAL GENERAL DE LANZAROTE   (Spain)

Author keywords

Chronic subclinical inflammation; Glycated haemoglobin; Insulin resistance; New onset diabetes after transplantation (NODAT)

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; BASILIXIMAB; C REACTIVE PROTEIN; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC INFLAMMATION; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIABETES MELLITUS; DIET RESTRICTION; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; INSULIN SENSITIVITY; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CHRONIC DISEASE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HOMEOSTASIS; HUMANS; INFLAMMATION; INSULIN RESISTANCE; KIDNEY TRANSPLANTATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; TIME FACTORS; TRIGLYCERIDES;

EID: 34547851685     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm067     Document Type: Article

References (32)

1. Willerson J, Ridker P. Inflammation as a cardiovascular risk factor. Circulation 2004; 109 [Suppl II]: 2-10
2. Menon V, Greene T, Wang X et al. C-reactive protein and albumin as predictors of all cause and cardiovascular mortality in chronic kidney disease. Kidney Int 2005; l: 95-102
3. Chen J, Wildman R, Hamm L et al. Association between inflammation and insulin resistance in U.S. Nondiabetic Adults. Diabetes Care 2004; 27: 2960-2965
4. Frohlich M, Imhof A, Berg G et al. Association between C-reactive protein and features of the metabolic syndrome. Diabetes Care 2000; 23: 1835-1839
5. Duncam B, Schimidt M, Pankow J et al. Low-grade systemic inflammation and the development of type 2 diabetes. The atherosclerosis risk in communities study. Diabetes 2003; 52: 1799-1805
6. Freeman D, Norrie J, Caslake M et al. for the West of Scotland coronary prevention study group. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland coronary prevention study. Diabetes 2002; 51: 1596-1600
7. Gustavsson C, Agardh C. Markers of inflammation in patients with coronary artery disease are also associated with glycosilated haemoglobin Alc within the normal range. European Heart J 2004; 25: 2120-2124
8. Ducloux D, Kazory A, Chalopin JM et al. Posttransplant diabetes mellitus and atherosclerotic events in renal transplant recipients: A prospective study. Transplantation 2005; 79: 438-443
9. Varagunam M, Finney H, Trevit R et al. Pretransplantation levels of C-reactive protein predict all-cause and cardiovascular mortality, but not graft outcome, in kidney transplant recipients. Am J Kid Dis 2004; 43: 502-507
10. Winkelmayer W, Lorenz M, Kramar R, Fodinger M, Horl W, Sunder-Plassman G. C-reactive protein and body mass index independently predict mortality in kidney transplant recipients. Am J Transplant 2004; 4: 1148-1154
11. van Ree R, de Vries A, Oterdoom L et al. Abdominal obesity and smoking are important determinants of C-reactive protein in renal transplant recipients. Nephrol Dial Transplant 2005; 20: 2524-2532
12. Porrini E, Delgado P, Bigo C et al. Impact of metabolic syndrome on graft function and survival after cadaveric renal transplantation. Am J Kidney Dis 2006; 48: 134-142
13. Anonymous. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005; 28 [Suppl 1]: S37-S42
14. Anonymous. Third report of the National Cholesterol Education Program CNCEP) expert panel on detection, evaluation and treatment of high cholesterol in adults (Adult Treatment panel III) final report. Circulation 2002; 106: 3143-3421
15. Meigs J, Wilson P, Nathan D et al. Prevalence and characteristics of the metabolic syndrome in the San Antonio and Framingham offspring studies. Diabetes 2003; 52: 2160-2167
16. Mariat C, Alamartine E, Barthelemy JC et al. Assessing renal graft function in clinical trials: Can tests predict glomerular filtration rate substitute for a reference method? Kidney Int 2003; 65: 289-297
17. Hjelmesæth J, Midtvedt K, Jenssen T, Hartmann A. Insulin resistance after renal transplantation. Impact of immunosuppressive and antihypertensive therapy. Diabetes Care 2001; 24: 2121-2126
18. Oterdoom L, de Vries A, van Son W et al. Validation of insulin resistance indexes in stable renal transplant population. Diabetes Care 2005; 10: 2424-2429
19. Pepys M, Hirschfield G. C-reactive protein: A critical update. J Clin Invest 2003; 111: 1805-1012
20. Ridker P, Wilson P, Grundy S. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk. Circulation 2004; 109: 2818-2825
21. Hansson G. Inflammation, atherosclerosis and coronary artery disease. N Engl J Med 2005; 352: 1685-1695
22. Reaven G. Importance of identifying the overweight patient who will benefit the most by losing weight. Ann Int Med 2003; 138: 420-424
23. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Int Med 2003; 139: 803-809
24. Pearson T, Mensah G, Wayne A et al. Markers of inflammation and cardiovascular disease. Application to clinical and public health practice. A statement for healthcare professionals from the centers for disease control and prevention and the American Health Service. Circulation 2003; 107: 499-511
25. Wu T, Dorn J, Donahue R, Sempos C, Trevisan M. Associations of serum C-reactive protein with fasting insulin, glucose, and glycosilated haemoglobin. Am J of Epidemiology 2002; 155: 65-71
26. Shoelson S, Lee J, Goldfine A. Inflammation and insulin resistance. J Clin. Invest 2006; 116: 1793-1801
27. Aronson D, Bartha P, Zinder O et al. Association between fasting glucose and C-reactive protein in middle-aged subjects. Diabetic Medicine 2004; 21: 39-44
28. Festa A, D'Agostino Howard G, Mykkänen L, Rusell T, Haffner S. Chronic subclinical inflammation as part of the insulin resistance syndrome. The Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102: 42-47
29. Meigs J, Nathan D, Wilson P, Cupples A, Singer D. Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance. Ann Int Med 1998; 128: 524-533
30. Ates K, Yilmaz O, Kutlay S, Ates A, Nergizoglu G, Erturk S. Serum C-reactive protein level is associated with renal function and it affects echocardiographic cardiovascular disease in predialysis patients. Nephron Clin Pract 2005; 101: 190-197
31. Stuveling E, Hillege H, Bakker S, Gans R, de Jong P, de Zeeuw. C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int 2003; 63: 654-661
32. Menon V, Wang X, Greene T et al. Relationship between C-reactive protein, albumin and cardiovascular disease in patients with chronic kidney disease. Am J Kid Dis 2003; 42: 44-52